Czech National Bank’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.05M Buy
41,288
+1,613
+4% +$334K 0.04% 320
2026
Q1
$8.91M Buy
39,675
+1,185
+3% +$295K 0.06% 276
2025
Q4
$9.27M Buy
38,490
+1,303
+4% +$333K 0.06% 265
2025
Q3
$10.2M Buy
37,187
+1,347
+4% +$368K 0.07% 243
2025
Q2
$9.25M Buy
35,840
+2,107
+6% +$503K 0.07% 241
2025
Q1
$7.55M Buy
33,733
+1,904
+6% +$444K 0.07% 258
2024
Q4
$7.28M Buy
31,829
+1,898
+6% +$457K 0.07% 253
2024
Q3
$7.31M Buy
29,931
+1,936
+7% +$433K 0.07% 253
2024
Q2
$5.36M Buy
27,995
+2,115
+8% +$429K 0.06% 282
2024
Q1
$5.13M Buy
25,880
+118
+0.5% +$21.6K 0.07% 279
2023
Q4
$4.43M Buy
25,762
+81
+0.3% +$12.4K 0.06% 292
2023
Q3
$3.8M Buy
25,681
+8,288
+48% +$1.5M 0.06% 299
2023
Q2
$3.8M Buy
17,393
+86
+0.5% +$19.2K 0.09% 235
2023
Q1
$3.79M Buy
17,307
+168
+1% +$36.4K 0.09% 230
2022
Q4
$3.57M Buy
17,139
+122
+0.7% +$26.8K 0.09% 234
2022
Q3
$3.71M Buy
+17,017
New +$3.87M 0.11% 204

Other funds holding RMD

Czech National Bank's RMD Position: Q2 2026 in Review

Czech National Bank increased its ResMed (RMD) stake by 4.1% in Q2 2026, buying an estimated $334K and bringing the position to 41,288 shares worth $8.05M. The position accounts for 0.04% of the portfolio, ranked #320.

Czech National Bank first reported a position in RMD in Q3 2022 and has held it in 16 quarters since. The position peaked at $10.2M in Q3 2025. 170 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Czech National Bank held 41,288 shares of ResMed worth $8.05M as of Q2 2026.
  • Czech National Bank bought 1,613 ResMed shares in Q2 2026, an estimated $334K.
  • ResMed made up 0.04% of Czech National Bank's portfolio in Q2 2026, its #320 holding.
  • Czech National Bank first reported a position in ResMed in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's ResMed position peaked at $10.2M in Q3 2025.
  • 170 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.